ArticleThe Lancet regional health. Europe2022

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study.

Jakob S Knudsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.